The Revolution of GLP-1 Medications for Diabetes Management in the United StatesIn the landscape of Type 2 Diabetes (T2D) treatment, few innovations have actually sparked as much interest-- both medical and mainstream-- as Glucagon-Like Peptide-1 (GLP-1) receptor agonists. Once medicshop4all of injectables, these medications have relocated to the leading edge
